This federal Project Grant award from the Department of Health and Human Services National Institutes of Health Office of the Director provided $14,427,699 to New York University School of Medicine for the period of May 24, 2021 through May 23, 2022. The award was made under the Lung Diseases Research program (CFDA #93.838) to support the POST-ACUTE SEQUELAE OF SARS-COV-2 INFECTION INITIATIVE: NYU LANGONE HEALTH CLINICAL SCIENCE CORE, DATA RESOURCE CORE, AND PASC BIOREPOSITORY CORE.
Specifically, the funding supports establishment and coordination of clinical evaluation sites, data coordination, and biorepository functions to study post-acute sequelae of SARS-CoV-2 infection, or "long COVID." Subawards were provided to various academic and research institutions totaling over $14 million to establish clinical evaluation sites and support data coordination and biorepository roles within the initiative. This large-scale, multi-site initiative will advance the understanding of long-term health impacts of COVID-19 to improve care for affected individuals.
Generated 1/6/24, 10:21 AM